For GPi DBS, Vingerhoets et al. compared the cognitive outcomes at the 3-month follow-up to that at the preoperative baseline in a cohort of PD patients who received unilateral left- (n = 13) or right-sided (n = 7) GPi DBS in the on-medication condition24. This evidence concerns the gene GPI and Parkinson disease.